ADME-Tox in drug discovery: integration of experimental and computational technologies
Owner/Developer: Drug Discovery Today
Over the past ten years, in vitro experimental tools to characterize ADME-Tox profiles of compounds have been applied in early stages of the drug discovery process to increase the success rate of discovery programmes and to progress better candidates into drug development. Application of in silico ADME-Tox models has further enhanced discovery support, enabling virtual screening of compounds and thus, application of ADME-Tox at every stage of the discovery process. Ultimately, effective and efficient ADME-Tox support of discovery will depend on a complementary and synergistic use of experimental and in silico ADME-Tox.
|Channel:||Website - Printed|
|Audience:||Researchers - Scientists - Industry|
|User access:||Restricted access|
|Relevance:||Replacement - Reduction|
|Purpose:||Method development - Documentation and information|
|Technology/Tools:||Alternative test methods (in vitro) - Non-testing methods (in silico)|
Did you find what you were looking for?Yes, I found it! No, I did not!
Thanks for your feedback! Please note that we cannot respond unless you supply your email address.
What are you looking for?
Please give us your feedback so we can improve the information on the page. Thank you in advance for your help. Please add your email address if you would like a reply.Please contact us by email if you have any questions.